204 related articles for article (PubMed ID: 9613123)
1. [Diagnostic significance of telomerase activity and telomere length in endoscopic sample of colorectal cancer].
Katayama S; Shiota G; Kawasaki H
Nihon Rinsho; 1998 May; 56(5):1204-8. PubMed ID: 9613123
[TBL] [Abstract][Full Text] [Related]
2. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
3. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
Abe N; Watanabe T; Nakashima M; Masaki T; Mori T; Sugiyama M; Atomi Y
Hepatogastroenterology; 2001; 48(39):692-5. PubMed ID: 11462905
[TBL] [Abstract][Full Text] [Related]
5. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.
Takagi S; Kinouchi Y; Hiwatashi N; Chida M; Nagashima F; Takahashi S; Negoro K; Shimosegawa T; Toyota T
Cancer; 1999 Oct; 86(8):1431-6. PubMed ID: 10526269
[TBL] [Abstract][Full Text] [Related]
6. [Detection of telomerase activity in intestinal lavage solution from colorectal carcinoma patients].
Ishibashi K; Wakasugi S; Ogawa K; Kato H; Endo S; Yoshimatsu K; Haga S; Hirose K; Kajiwara T
Nihon Rinsho; 1998 May; 56(5):1209-13. PubMed ID: 9613124
[TBL] [Abstract][Full Text] [Related]
7. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of telomerase activity and telomere length in the preoperative diagnosis of gastric and colorectal cancer.
Katayama S; Shiota G; Oshimura M; Kawasaki H
J Cancer Res Clin Oncol; 1999 Jul; 125(7):405-10. PubMed ID: 10394961
[TBL] [Abstract][Full Text] [Related]
10. Determination of telomerase activity and telomere length.
Wu KD; Moore MA
Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105
[TBL] [Abstract][Full Text] [Related]
11. [Telomerase activity and telomere length as diagnostic tumor marker for ovarian tumors].
Murakami J; Nagai N; Ohama K
Nihon Rinsho; 1998 May; 56(5):1310-5. PubMed ID: 9613143
[TBL] [Abstract][Full Text] [Related]
12. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
13. [Telomere length and telomerase activity in hepatocellular carcinoma].
Nakashio R; Kitamoto M; Nakanishi T; Takaishi H; Takahashi S; Kajiyama G
Nihon Rinsho; 1998 May; 56(5):1239-43. PubMed ID: 9613130
[TBL] [Abstract][Full Text] [Related]
14. Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length.
Kojima H; Miyazaki H; Shiwa M; Tanaka Y; Moriyama H
Laryngoscope; 2001 May; 111(5):867-73. PubMed ID: 11359168
[TBL] [Abstract][Full Text] [Related]
15. [Methods of measuring telomere length and telomerase activity--practice and problems].
Saito Y; Suda T; Hatakeyama K
Nihon Rinsho; 1998 May; 56(5):1153-8. PubMed ID: 9613113
[TBL] [Abstract][Full Text] [Related]
16. [Telomere length and telomerase activity in intestinal metaplasia, adenoma and well differentiated adenocarcinoma of the stomach].
Maruyama Y; Hanai H; Kaneko E
Nihon Rinsho; 1998 May; 56(5):1186-9. PubMed ID: 9613119
[TBL] [Abstract][Full Text] [Related]
17. Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological features.
Izgi A; Gunal A; Yalcin S; Gunduz U
Biomed Pharmacother; 2014 Sep; 68(7):841-6. PubMed ID: 25194444
[TBL] [Abstract][Full Text] [Related]
18. The relationship between telomere length and telomerase activity in gynecologic cancers.
Wang SJ; Sakamoto T; Yasuda Si S; Fukasawa I; Ota Y; Hayashi M; Okura T; Zheng JH; Inaba N
Gynecol Oncol; 2002 Jan; 84(1):81-4. PubMed ID: 11748981
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in ovarian tumors.
Murakami J; Nagai N; Ohama K; Tahara H; Ide T
Cancer; 1997 Sep; 80(6):1085-92. PubMed ID: 9305709
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity and telomere length in primary and metastatic tumors from pediatric bone cancer patients.
Sotillo-Piñeiro E; Sierrasesúmaga L; Patiñno-García A
Pediatr Res; 2004 Feb; 55(2):231-5. PubMed ID: 14630995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
